The sales are routine in size (<0.05% of $363M market cap) and likely related to personal financial planning. No cause for concern unless followed by further selling or negative news. Monitor upcoming earnings or clinical trial updates.
Price Chart
Executive Summary
Two C-suite executives at Avalo Therapeutics — the CFO and Chief Medical Officer — sold shares worth $177K in the past week, with open-market transactions totaling 10,170 shares. The sales represent a modest portion of their holdings but are not indicative of a major strategic shift.
Key Financial Metrics
Key Facts
- CFO Sullivan Christopher Ryan sold 6,200 shares at $17.02 for $105,553.14 on April 2, 2026.
- Chief Medical Officer Doyle Mittie sold 3,970 shares at $18.01 for $71,508.43 on April 6, 2026.
- Doyle Mittie also exercised derivative securities for 7,940 shares, with $50,220.5 in value related to one tranche.
- Total open-market sale value from both insiders: $177,061.57.
- No other insiders reported transactions in this 7-day cluster window.
Financial Impact
$177K in open-market sales over 7 days
Risk Factors
- Concentrated insider selling could signal reduced confidence if it continues.
- Biotech stocks are sensitive to leadership actions; even small sales can be misinterpreted by the market.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 1 SEC document filed with EDGAR.
| Document | Accession Number |
|---|---|
| CLUSTER Data (Synthetic) | cluster-AVTX-1775681542954 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Aug 19, 2026 6w ago | Insider Cluster | $20.75 $16.69 | ▼ −19.57% | ▼ −17.61% | $14.99 (−27.76%) |
Aug 17, 2026 6w ago | Institutional Cluster | $19.95 $16.07 | ▼ −19.45% | ▼ −17.47% | $14.99 (−24.86%) |
Aug 6, 2026 8w ago | 8-K | $18.70 $19.00 | ▲ +1.60% | ▲ +1.00% | $14.99 (−19.84%) |
Jun 16, 2026 15w ago | 8-K | $14.33 $18.42 | ▲ +28.54% | ▲ +28.34% | $14.99 (+4.61%) |
Jun 16, 2026 15w ago | Press Release | $14.33 $18.42 | ▲ +28.54% | ▲ +28.34% | $14.99 (+4.61%) |
Jun 8, 2026 16w ago | 8-K | $12.90 $19.25 | ▲ +49.22% | ▲ +47.78% | $14.99 (+16.20%) |
May 13, 2026 20w ago | 8-K | $19.85 $13.67 | ▼ −31.13% | ▼ −30.52% | $14.99 (−24.48%) |
May 13, 2026 20w ago | Press Release | $19.85 $13.67 | ▼ −31.13% | ▼ −30.52% | $14.99 (−24.48%) |
May 6, 2026 21w ago | Press Release | $21.81 $13.74 | ▲ +37.00% | ▲ +39.78% | $14.99 (+31.27%) |
May 6, 2026 21w ago | Insider Cluster | $21.81 $13.74 | ▲ +37.00% | ▲ +39.78% | $14.99 (+31.27%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access